TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
137 hedge funds and large institutions have $818M invested in Trillium Therapeutics Inc. in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 45 increasing their positions, 38 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1% more capital invested
Capital invested by funds: $812M → $818M (+$6.42M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
137
Holding in Top 10
3
Calls
$9.33M
Puts
$4.01M
Top Buyers
| 1 | +$54.5M | |
| 2 | +$18M | |
| 3 | +$13.2M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$12.8M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$8.06M |
Top Sellers
| 1 | -$19.8M | |
| 2 | -$8.55M | |
| 3 | -$7.2M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$7.11M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$6.79M |